Your browser doesn't support javascript.
loading
Safety profile of nivolumab administered as 30-min infusion: analysis of data from CheckMate 153.
Waterhouse, David; Horn, Leora; Reynolds, Craig; Spigel, David; Chandler, Jason; Mekhail, Tarek; Mohamed, Mohamed; Creelan, Ben; Blankstein, Kenneth B; Nikolinakos, Petros; McCleod, Michael J; Li, Ang; Oukessou, Abderrahim; Agrawal, Shruti; Aanur, Nivedita.
Affiliation
  • Waterhouse D; Oncology Hematology Care, Cincinnati, OH, USA. David.waterhouse@usoncology.com.
  • Horn L; US Oncology Research, Houston, TX, USA. David.waterhouse@usoncology.com.
  • Reynolds C; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Spigel D; Ocala Oncology Center, Ocala, FL, USA.
  • Chandler J; US Oncology Research, Houston, TX, USA.
  • Mekhail T; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, USA.
  • Mohamed M; West Cancer Center, PC, Memphis, TN, USA.
  • Creelan B; Florida Hospital Cancer Institute, Orlando, FL, USA.
  • Blankstein KB; Cone Health Cancer Center at Wesley Long, Greensboro, NC, USA.
  • Nikolinakos P; H. Lee Moffitt Cancer Center, Tampa, FL, USA.
  • McCleod MJ; Hunterdon Hematology Oncology, Flemington, NJ, USA.
  • Li A; University Cancer and Blood Center, LLC, Athens, GA, USA.
  • Oukessou A; Florida Cancer Specialists, Cape Coral, FL, USA.
  • Agrawal S; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Aanur N; Bristol-Myers Squibb, Princeton, NJ, USA.
Cancer Chemother Pharmacol ; 81(4): 679-686, 2018 04.
Article in En | MEDLINE | ID: mdl-29442139

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Antineoplastic Agents, Immunological / Nivolumab / Lung Neoplasms / Neoplasm Recurrence, Local Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2018 Document type: Article Affiliation country: United States Country of publication: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Antineoplastic Agents, Immunological / Nivolumab / Lung Neoplasms / Neoplasm Recurrence, Local Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2018 Document type: Article Affiliation country: United States Country of publication: Germany